Novo Holdings A/S Long-Term Concentrated

CIK: 0001388325 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 14, 2023

Total Value ($000): $1,294,171 (100.0% shares, 0.0% debt)

Holdings (41)

ASML ASML HOLDING N V 11.1%
Value ($000) $143,327 Shares 197,760 Est. Cost $654.82 Unrealized
CRM SALESFORCE.COM, INC. 8.7%
Value ($000) $112,073 Shares 530,500 Est. Cost $193.03 Unrealized +4.5%
LANZATECH GLOBAL INC 8.3%
Value ($000) $108,015 Shares 15,814,845 Est. Cost $3.88 Unrealized
CORT CORCEPT THERAPEUTICS INC 5.8%
Value ($000) $75,155 Shares 3,377,768 Est. Cost $23.02 Unrealized +0.0%
TSM TAIWAN SEMICONDUCTOR MFG LTD 5.5%
Value ($000) $71,732 Shares 710,780 Est. Cost $96.28 Unrealized
CABO CABLE ONE INC 4.8%
Value ($000) $61,833 Shares 94,103 Est. Cost $1080.67 Unrealized -40.8%
IRON DISC MEDICINE, INC. 3.7%
Value ($000) $48,430 Shares 1,090,772 Est. Cost $49.79 Unrealized -28.7%
EWTX EDGEWISE THERAPEUTICS INC 3.6%
Value ($000) $47,056 Shares 6,071,703 Est. Cost $30.65 Unrealized -72.5%
MIRM MIRUM PHARMACEUTICALS INC 3.4%
Value ($000) $43,570 Shares 1,684,193 Est. Cost $12.27 Unrealized +116.8%
AAPL APPLE INC 3.3%
Value ($000) $42,957 Shares 221,460 Est. Cost $90.57 Unrealized +90.0%
PCVX VAXCYTE INC 3.3%
Value ($000) $42,199 Shares 845,000 Est. Cost $26.47 Unrealized +79.1%
BABA ALIBABA GROUP HLDG LTD 3.2%
Value ($000) $41,744 Shares 500,827 Est. Cost $165.09 Unrealized
BMRN BIOMARIN PHARMACEUTICAL INC 2.7%
Value ($000) $34,672 Shares 400,000 Est. Cost $83.79 Unrealized +12.3%
ACLX ARCELLX, INC. 2.4%
Value ($000) $31,620 Shares 1,000,000 Est. Cost $16.72 Unrealized +128.7%
SEAGEN INC. 2.4%
Value ($000) $30,791 Shares 159,986 Est. Cost $141.01 Unrealized
BLUEPRINT MEDICINES CORP 2.2%
Value ($000) $28,364 Shares 448,804 Est. Cost $61.37 Unrealized
INSM INSMED INC 2.2%
Value ($000) $28,259 Shares 1,339,304 Est. Cost $23.10 Unrealized -17.9%
FOLD AMICUS THERAPEUTICS INC 2.0%
Value ($000) $26,325 Shares 2,095,900 Est. Cost $13.12 Unrealized -9.5%
ALNY ALNYLAM PHARMACEUTICALS INC 1.7%
Value ($000) $22,486 Shares 118,383 Est. Cost $160.04 Unrealized +23.9%
CYMABAY THERAPEUTICS INC 1.7%
Value ($000) $21,900 Shares 2,000,000 Est. Cost $10.95 Unrealized
RENEO PHARMACEUTICALS INC 1.7%
Value ($000) $21,847 Shares 3,330,377 Est. Cost $9.33 Unrealized
BROOKFIELD ASSET MGMT INC 1.6%
Value ($000) $20,466 Shares 627,207 Est. Cost $36.83 Unrealized
PHVS PHARVARIS N V 1.6%
Value ($000) $20,126 Shares 1,329,325 Est. Cost $11.67 Unrealized -17.5%
CRNX CRINETICS PHARMACEUTICALS IN 1.5%
Value ($000) $19,822 Shares 1,100,000 Est. Cost $19.36 Unrealized +3.0%
RCKT ROCKET PHARMACEUTICALS INC 1.4%
Value ($000) $18,280 Shares 920,000 Est. Cost $29.56 Unrealized -31.7%
FDMT 4D MOLECULAR THERAPEUTICS IN 1.4%
Value ($000) $18,070 Shares 1,000,000 Est. Cost $19.14 Unrealized -3.8%
SPRUCE BIOSCIENCES INC 1.1%
Value ($000) $14,453 Shares 6,722,336 Est. Cost $17.05 Unrealized
RALLYBIO CORP 1.0%
Value ($000) $12,384 Shares 2,187,999 Est. Cost $6.73 Unrealized
SILK RD MED INC 0.8%
Value ($000) $10,848 Shares 333,884 Est. Cost $41.80 Unrealized
INSP INSPIRE MED SYS INC 0.8%
Value ($000) $10,551 Shares 32,500 Est. Cost $167.02 Unrealized +71.1%
CYTEIR THERAPEUTICS INC 0.7%
Value ($000) $9,523 Shares 3,662,636 Est. Cost $21.40 Unrealized
VERVE THERAPEUTICS INC 0.7%
Value ($000) $9,375 Shares 500,000 Est. Cost $39.25 Unrealized
TMCI TREACE MED CONCEPTS INC 0.7%
Value ($000) $9,209 Shares 360,000 Est. Cost $25.28 Unrealized +2.1%
ABCL ABCELLERA BIOLOGICS INC 0.6%
Value ($000) $7,280 Shares 1,126,915 Est. Cost $8.47 Unrealized -19.4%
GRTX GALERA THERAPEUTICS INC 0.5%
Value ($000) $6,552 Shares 2,100,000 Est. Cost $12.19 Unrealized -75.6%
IOBT IO BIOTECH INC 0.5%
Value ($000) $6,408 Shares 3,277,932 Est. Cost $9.66 Unrealized -79.8%
GALECTO INC 0.5%
Value ($000) $6,294 Shares 2,497,791 Est. Cost $12.51 Unrealized
LAVA THERAPEUTICS NV 0.4%
Value ($000) $4,872 Shares 2,400,000 Est. Cost $15.19 Unrealized
KINNATE BIOPHARMA INC 0.2%
Value ($000) $2,472 Shares 815,707 Est. Cost $25.36 Unrealized
MQ MARQETA INC 0.2%
Value ($000) $2,150 Shares 441,558 Est. Cost $22.37 Unrealized -79.7%
SPRO SPERO THERAPEUTICS INC 0.1%
Value ($000) $680 Shares 468,902 Est. Cost $11.41 Unrealized -85.0%